Flow cytometric analyses revealed only minor expression of CCR2 on myeloid cells (CD11b+CD45+) in naïve mouse brains while CCR2 was up-regulated in tumor-bearing mice (Figure 1f). This evidence concerns the gene CCR2 and neoplasm.